Abstract
Analytical methods are critical in the characterization and testing of cell and gene therapy products. Analytical method development occurs in parallel to product development and is refined as knowledge is accumulated during the development program. Validated analytical methods are generally required for product licensure, and steps should be taken to build towards analytical method validation as product development progresses towards release. Here we consider approaches for streamlining analytical method development via well-coordinated product and analytical method development efforts. We further discuss the importance of establishing a robust measurement infrastructure, including key aspects, such as measurement assurance strategies, measurement platforms with well-understood capabilities and limitations, standards to support rapid validation of a given measurement platform, as well as enabling tools and technologies to streamline and integrate various processes and data.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
